The Current Ratio as of November 2024 (TTM) for InVivo Therapeutics Holdings Corp. (NVIV) is 14.30

According to InVivo Therapeutics Holdings Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 14.30. This represents a change of 45.10% compared to the average of 9.86 of the last 4 quarters.

InVivo Therapeutics Holdings Corp. (NVIV) Historical Current Ratio (quarterly & annually)

How has NVIV Current Ratio performed in the past?

The mean historical Current Ratio of InVivo Therapeutics Holdings Corp. over the last ten years is 6.05. The current 14.30 Current Ratio has changed 23.54% with respect to the historical average. Over the past ten years (40 quarters), NVIV's Current Ratio was at its highest in in the March 2021 quarter at 17.30. The Current Ratio was at its lowest in in the June 2018 quarter at 0.92.

InVivo Therapeutics Holdings Corp. (NVIV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of InVivo Therapeutics Holdings Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InVivo Therapeutics Holdings Corp. (NVIV) Average Current Ratio

How has NVIV Current Ratio performed in the past?

The current Current Ratio of InVivo Therapeutics Holdings Corp. (NVIV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

InVivo Therapeutics Holdings Corp. (NVIV) Current Ratio vs. Peers

How is NVIV’s Current Ratio compared to its peers?

InVivo Therapeutics Holdings Corp.’s Current Ratio is less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), greater than Revelation Biosciences, Inc. (1.64), greater than Hillstream BioPharma, Inc. (2.25), greater than Kiora Pharmaceuticals, Inc. (8.97), greater than NextCure, Inc. (9.07), greater than CytomX Therapeutics, Inc. (1.04), less than Neoleukin Therapeutics, Inc. (15.33), greater than Spero Therapeutics, Inc. (2.68), greater than Assembly Biosciences, Inc. (2.36), greater than Nutriband Inc. (6.57), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Longeveron Inc. (7.67), greater than RenovoRx, Inc. (5.40), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Rezolute, Inc. (13.79), greater than HCW Biologics Inc. (0.07), less than Eliem Therapeutics, Inc. (60.41), less than Molecular Partners AG (14.33), greater than Senti Biosciences, Inc. (1.92), greater than SAB Biotherapeutics, Inc. (3.69),

Build a custom stock screener for InVivo Therapeutics Holdings Corp. (NVIV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVivo Therapeutics Holdings Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVivo Therapeutics Holdings Corp. (NVIV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVivo Therapeutics Holdings Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.